Clinical trials sponsored by Shaare Zedek Medical Center

Phase breakdown

Conditions studied

Recruiting trials led by Shaare Zedek Medical Center

• Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer
  NCT03591276 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Pre-stenotic Inflammation Following Endoscopic Balloon Dilatation in Crohn's Disease: A Prospective Study
  NCT04803916 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Risankizumab in Children With Crohn's Disease (RisaKids)
  NCT06298188 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 18 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Shaare Zedek Medical Center recruiting for?

Shaare Zedek Medical Center is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.